CCL24



CCL24

V1VV1T2TT2I3II3P4PP4S5SS5S6SS6C7CC7C8CC8T9TT9S10SS10F11FF11I12II12S13SS13K14KK14K15KK15I16II16P17PP17E18EE18N19NN19R20RR20V21VV21V22VV22S23SS23Y24YY24Q25QQ25L26LL26A27AA27N28NN28G29GG29S30SS30I31II31C32CC32P33PP33K34KK34A35AA35G36GG36V37VV37I38II38F39FF39I40II40T41TT41K42KK42K43KK43G44GG44H45HH45K46KK46I47II47... and 46 more residue(s)...... and 46 more residue(s)

SMILES None
InChIKey None
Sequence VTIPSSCCTSFISKKIPENRVVSYQLANGSICPKAGVIFITKKGHKICTDPKLLWVQRHIQKLDAKKNQPSKGAKAVRTKFAVQRRRGNSTEV

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections



No bioactivity data available.

CCL24

V1VV1T2TT2I3II3P4PP4S5SS5S6SS6C7CC7C8CC8T9TT9S10SS10F11FF11I12II12S13SS13K14KK14K15KK15I16II16P17PP17E18EE18N19NN19R20RR20V21VV21V22VV22S23SS23Y24YY24Q25QQ25L26LL26A27AA27N28NN28G29GG29S30SS30I31II31C32CC32P33PP33K34KK34A35AA35G36GG36V37VV37I38II38F39FF39I40II40T41TT41K42KK42K43KK43G44GG44H45HH45K46KK46I47II47... and 46 more residue(s)...... and 46 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.